Brain scans found MS groups with different disability
Key Takeaway
Brain scans identified four MS groups that differed in disability and in how soon people worsened without a relapse.
What They Found
Researchers used brain scans to identify four MS groups, based on where damage appeared. Two groups had more people with progressive MS, while two had more people with relapsing-remitting MS. Disability was more common in the groups marked by damage to the brain's outer layer or deeper areas. These groups also worsened without a relapse sooner than the group marked mainly by lesions. Thinking test results and genetic risk did not differ across groups, but thinking scores were worse at more advanced scan stages within each group.
Who Should Care and Why
The study included people with MS and people without MS. It included people with relapsing-remitting MS and progressive MS. Researchers also compared MS that began in childhood, adulthood, or later life. One scan group was more common among people whose MS began in childhood. The findings show that scan patterns may describe differences that usual MS labels do not capture.
Important Considerations
You should know this was an observational study using scans from 1,264 people with MS and 689 people without MS across two groups. The study found links between scan patterns and disability; it did not test a treatment. The scan groups did not differ in thinking test results or genetic risk scores.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/16/2026
Two rare conditions can look like MS. An Italian study links certain treatments to more time without
Read More
10/15/2026
Researchers suggest adding a drug after stem cell transplant to help keep MS from returning. Learn h
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.